Top Markets
Coin of the day
Fischer Medical Ventures Ltd. Fischer Medical Ventures Ltd.

Fischer Medical Ventures Ltd.

FISCHER
Rank in Stocks #16812
Fischer Medical Ventures Limited, established in 1993 and headquartered in... Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Share Price
$0.41715616
Market Cap
$273.04M
Change (1 day)
2.41%
Change (1 year)
-65.48%
Country
IN
Trade Fischer Medical Ventures Ltd. (FISCHER)

Category

Revenue for Fischer Medical Ventures Ltd. (FISCHER)
Revenue in Sep 2026 TTM: 0
According to Fischer Medical Ventures Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Fischer Medical Ventures Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
$6.51B -
US